AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,332,000 | -26.2% | 395,500 | -17.6% | 0.50% | -32.9% |
| Q1 2021 | $8,578,000 | +177.8% | 480,000 | +638.5% | 0.74% | +18.7% |
| Q1 2019 | $3,088,000 | -42.9% | 65,000 | -18.8% | 0.63% | -39.7% |
| Q2 2018 | $5,404,000 | +37.9% | 80,000 | +22.0% | 1.04% | -31.4% |
| Q4 2017 | $3,920,000 | +41.5% | 65,600 | +15.1% | 1.52% | +90.3% |
| Q3 2017 | $2,771,000 | -18.9% | 57,000 | -12.3% | 0.80% | -33.5% |
| Q2 2017 | $3,416,000 | -20.7% | 65,000 | -31.6% | 1.20% | -43.2% |
| Q1 2017 | $4,308,000 | +17.9% | 95,000 | -1.6% | 2.11% | -3.0% |
| Q4 2016 | $3,653,000 | -3.2% | 96,500 | -3.5% | 2.18% | +41.1% |
| Q3 2016 | $3,774,000 | – | 100,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |